Treatment Switches in Spondyloarthritis

This chapter focuses on a study comparing the outcomes of patients with radiographic axial spondyloarthritis who either continued TNF inhibitors or switched to IL-17 inhibitors after treatment failure. Key findings reveal similarities in retention rates but significant differences in disease activity and side effects, stressing the necessity of personalized treatment approaches and shared decision-making.